Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%

Sophia Antipolis, France, May 31, 2017 — Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for…

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us